Frank Doyle — a prolific medical device inventor and Harvard engineering school leader — will discuss the future of medtech development during DeviceTalks Boston, May 10–11, 2022.
A pioneer in developing artificial pancreas technology to treat diabetes, Doyle will share his insights on the future of medical device development, including the expanding role of robotics and artificial intelligence.
Doyle is the Dean of the Harvard John A. Paulson School of Engineering and Applied Sciences. His success earned him election into the National Academy of Engineering last year (and National Academies of Medicine and Inventors before that).
Doyle will hit upon several critical areas during his keynote presentation at DeviceTalks Boston including:
- What lessons he learned from the many years spent developing the complicated systems and algorithms of an artificial pancreas and providing the support necessary to bring it to market.
- How, in his role as dean of Harvard Paulson School of Engineering and Applied Sciences (SEAS), he’s working to solidify SEAS’s position as a partner for industry and developer of the next generation of innovators.
- Where he sees medical device innovation benefiting from increased cooperation between engineering, business, and medical schools as well as hospitals, foundations and the government.
- What are the far-ranging capabilities of Harvard Paulson’s new 500,000 square-foot Science & Engineering Center – which opened in 2020 (and houses the $500m Chan Zuckerberg Initiative (CZI) Neuroscience AI program within it.)
- What the medical device industry can learn from – and teach to – leaders in the technology industry.
Doyle will be interviewed by Peter Stebbins, a medtech industry leader and former business development leader from Johnson & Johnson.
Questions from the audience will be encouraged in this wide-ranging discussion.
